3-(2-pyrrolyl)pyridazine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 3-(2-pyrrolyl)pyridazine
• 英文别名: 3-(1H-pyrrol-2-yl)pyridazine
• 化学式: C₈H₇N₃
• mdl: MFCD19220392
• 分子量: 145.164
• InChiKey: QFKXFTLPCRTWIO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  triethyloxonium fluoroborate 、 3-(2-pyrrolyl)pyridazine 以 1,2-二氯乙烷 为溶剂， 反应 2.0h， 以96%的产率得到1-ethyl-3-(2-pyrrolyl)pyridazinium tetrafluoroborate
  参考文献：
  名称：

  The synthesis and chemical reactivity of 3-chloro-6-(2-pyrrolyl)pyridazine

  摘要：

  DOI：

  10.1016/s0040-4020(98)00513-4
• 作为产物：
  描述：

  3-chloro-6-(2'-pyrrolyl)pyridazine 在 palladium on activated charcoal ammonium formate 作用下， 以 甲醇 为溶剂， 以89.3%的产率得到3-(2-pyrrolyl)pyridazine
  参考文献：
  名称：

  The synthesis and chemical reactivity of 3-chloro-6-(2-pyrrolyl)pyridazine

  摘要：

  DOI：

  10.1016/s0040-4020(98)00513-4

文献信息

• Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses
  申请人：Dubreuil Didier Max

  公开号：US20100298562A1

  公开（公告）日：2010-11-25

  The present invention relates to nonlinear oligopyridazine compounds, to processes for obtaining them, to their uses, and also to their reduction to oligopyrroles and to the uses of the pyridazinylpyrrole and oligopyrrole compounds obtained. The invention relates in particular to the uses as medicaments, in particular for treating pathologies such as cancer, bacterial infections or parasitic infections, and also the uses in the materials, environmental, electronics and optics field.

  本发明涉及非线性寡吡啶化合物，以及获得它们的方法，它们的用途，以及将它们还原为寡吡咯和所获得的吡啶基吡咯和寡吡咯化合物的用途。该发明特别涉及用作药物的用途，特别是用于治疗癌症、细菌感染或寄生虫感染等病理的用途，以及在材料、环境、电子和光学领域的用途。
• LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS
  申请人：Dubreuil Didier Max

  公开号：US20100004443A1

  公开（公告）日：2010-01-07

  The present invention relates to linear pyridazine compounds, and more particularly to those of these compounds which are oligopyridazine compounds, to processes for obtaining them, to their uses, and also to their reduction to pyrroles and to the uses of the pyrrole, pyridazinylpyrrole and oligopyrrole compounds obtained. The invention relates in particular to the uses as medicaments, in particular for treating pathologies such as cancer, bacterial infections or parasitic infections, and also the applications in the materials, environmental, electronics and optics field.

  本发明涉及线性吡啶二氮杂环化合物，更特别涉及这些化合物中的寡吡啶二氮杂环化合物，以及获取它们的方法、它们的用途，以及它们还原为吡咯并利用所得的吡咯、吡啶二氮杂吡咯和寡吡咯化合物的用途。本发明特别涉及作为药物的用途，特别是用于治疗癌症、细菌感染或寄生虫感染等病理情况，以及在材料、环境、电子和光学领域的应用。
• Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions
  申请人：——

  公开号：US20040072018A1

  公开（公告）日：2004-04-15

  The present invention relates to polymeric metal complexes comprising metallic complexes covalently bound to conjugated polymers and luminescent materials containing such polymeric metal complexes. The invention further relates to electronic devices in which the active layer includes such polymeric metal complexes.

  本发明涉及聚合物金属配合物，其包括共价结合到共轭聚合物和含有这种聚合物金属配合物的发光材料的金属配合物。本发明还涉及包括这种聚合物金属配合物的活性层的电子器件。
• Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
  申请人：E.I. DUPONT DE NEMOURS AND COMPANY

  公开号：EP2034000A2

  公开（公告）日：2009-03-11

  The invention relates to electroluminescent Ir(III) complexes, and active layers and devices comprising the Ir(III) complexes. The complexes have emission maxima in the red-orange to red region of the visible spectrum.

  本发明涉及电致发光的 Ir(III)络合物，以及包含 Ir(III)络合物的活性层和器件。这些配合物在可见光谱的橘红色至红色区域具有最大发射光谱。
• Electroluminescent iridium compounds
  申请人：E. I. du Pont de Nemours and Company

  公开号：EP2325279A2

  公开（公告）日：2011-05-25

  The present invention relates to electroluminescent Ir(III) complexes, and active layers and devices comprising the Ir(III) complexes. The complexes have emission maxima in the red-orange to red region of the visible spectrum.

  本发明涉及电致发光的 Ir(III)配合物，以及包含 Ir(III)配合物的活性层和器件。这些配合物在可见光谱的橘红色至红色区域具有最大发射光谱。